Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - Nordics

Nordics

Revenue in the Diabetes Care Devices market market in the Nordics is projected to reach US$0.52bn in 2024.
Revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 11.60%, leading to a market volume of US$0.90bn by 2029.
In a global context, the highest revenue will be generated the United States, with a forecast of US$11,710.00m in 2024.
In the Nordics, there is a growing emphasis on integrating digital health solutions into diabetes care devices, enhancing patient engagement and remote monitoring capabilities.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Diabetes Care Devices Market in the Nordics is witnessing considerable growth, fueled by factors like technological advancements, increasing prevalence of diabetes, and heightened consumer awareness regarding effective management of the condition.

Customer preferences: In the Nordics, consumers are increasingly prioritizing personalized diabetes management solutions that integrate seamlessly with their daily lives. This shift is characterized by a growing preference for smart insulin delivery systems and continuous glucose monitoring devices that offer real-time data and insights. Additionally, cultural emphasis on sustainability is prompting demand for eco-friendly devices. As the population ages and lifestyles evolve, there is heightened interest in telehealth services, enabling remote consultations and support, thus enhancing the overall diabetes care experience.

Trends in the market: In the Nordics, the Diabetes Care Devices Market is experiencing a significant shift towards interconnected, user-friendly solutions that prioritize patient engagement. Smart insulin delivery systems and continuous glucose monitoring devices are increasingly popular, offering users real-time insights into their glucose levels. Additionally, the trend towards sustainability is driving demand for eco-conscious products, aligning with regional values. The aging population and evolving lifestyles are fostering interest in telehealth services, facilitating remote consultations and enhancing patient support, which could reshape the industry landscape and create new opportunities for stakeholders.

Local special circumstances: In the Nordics, the Diabetes Care Devices Market is shaped by a strong emphasis on patient-centered care and a robust welfare system that promotes health equity. Geographically, the region's remote areas are driving innovation in telehealth services, ensuring access to care for all patients, regardless of location. Culturally, there is a high value placed on sustainability, which influences the demand for eco-friendly diabetes products. Regulatory frameworks in the Nordics support rigorous safety standards, fostering trust in new technologies and encouraging investment in advanced diabetes management solutions.

Underlying macroeconomic factors: The Diabetes Care Devices Market in the Nordics is significantly influenced by macroeconomic factors such as robust national healthcare spending, innovative public-private partnerships, and a focus on preventative care. The region benefits from strong economic stability, enabling investments in advanced medical technologies. Favorable fiscal policies, including subsidies for diabetes management solutions, enhance market accessibility. Additionally, the growing emphasis on digital health and telemedicine aligns with global trends toward personalized care, driving demand for innovative diabetes management devices that cater to diverse patient needs and promote sustainable health outcomes.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.